Catalyst Pharmaceuticals Management
Management Kriterienprüfungen 2/4
Catalyst Pharmaceuticals' CEO is Rich Daly, appointed in Jan 2024, has a tenure of less than a year. directly owns 0.2% of the company’s shares, worth $3.52M. The average tenure of the management team and the board of directors is 3.5 years and 11.5 years respectively.
Wichtige Informationen
Rich Daly
Geschäftsführender
US$14.1m
Gesamtvergütung
Prozentsatz des Geschäftsführergehalts | n/a |
Amtszeit als Geschäftsführer | less than a year |
Eigentum des Geschäftsführers | 0.2% |
Durchschnittliche Amtszeit des Managements | 3.5yrs |
Durchschnittliche Amtszeit der Vorstandsmitglieder | 11.5yrs |
Jüngste Management Updates
Recent updates
Catalyst Pharmaceuticals: Revenue Growth Lagging Expense Growth (Rating Downgrade)
Apr 06Earnings Tell The Story For Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX)
Jan 29Catalyst Pharmaceuticals: Until The TEVA ANDA Is Resolved, There Is A Risk
Jan 17With EPS Growth And More, Catalyst Pharmaceuticals (NASDAQ:CPRX) Makes An Interesting Case
Sep 06Should You Be Adding Catalyst Pharmaceuticals (NASDAQ:CPRX) To Your Watchlist Today?
May 27Do Catalyst Pharmaceuticals' (NASDAQ:CPRX) Earnings Warrant Your Attention?
Feb 13Is Now The Time To Put Catalyst Pharmaceuticals (NASDAQ:CPRX) On Your Watchlist?
Nov 11Catalyst Pharmaceuticals gains 9% on SmallCap 600 addition
Sep 12Catalyst Pharma ends momentum as Roth downgrades
Aug 24Catalyst Pharmaceuticals: Performing Above Expectations
Aug 12Catalyst: Upside Outlier - In Search Of A Catalyst
May 11Geschäftsführer
Rich Daly (63 yo)
less than a year
Amtszeit
US$14,076,923
Vergütung
Mr. Richard John Daly, also known as Rich, MBA, had been an Independent Director at Catalyst Pharmaceuticals, Inc. from February 2015 until January 1, 2024 and serves as its Chief Executive Officer and Dir...
Führungsteam
Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
---|---|---|---|---|
President | less than a year | US$14.08m | 0.20% $ 3.5m | |
Executive VP | 14.7yrs | US$3.40m | 0.70% $ 12.4m | |
Chief Medical & Regulatory Officer | 9yrs | US$2.37m | 0.044% $ 770.9k | |
Executive VP & Chief Commercial Officer | 4yrs | US$2.51m | 0.016% $ 276.4k | |
Executive VP | less than a year | keine Daten | keine Daten | |
VP & Head of Investor Relations | 2.8yrs | keine Daten | keine Daten | |
Chief Compliance Officer & Chief Legal Officer | 8.3yrs | US$353.27k | 0.11% $ 1.9m | |
Vice President of Sales | 4yrs | keine Daten | keine Daten | |
Senior Vice President of Medical Affairs & Drug Discovery | 1.3yrs | keine Daten | keine Daten | |
Chief Strategy Officer | 2.9yrs | US$1.70m | 0.022% $ 383.0k | |
Corporate Secretary | no data | keine Daten | keine Daten |
3.5yrs
Durchschnittliche Betriebszugehörigkeit
61yo
Durchschnittliches Alter
Erfahrenes Management: CPRX's management team is considered experienced (3.5 years average tenure).
Vorstandsmitglieder
Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
---|---|---|---|---|
President | 9.3yrs | US$14.08m | 0.20% $ 3.5m | |
Independent Director | 21.7yrs | US$370.99k | 0.30% $ 5.2m | |
Co-Founder & Chairman | 22.4yrs | US$2.15m | 3.83% $ 67.9m | |
Independent Director | 9.3yrs | US$376.24k | 0.37% $ 6.6m | |
Lead Independent Director | 19.5yrs | US$397.24k | 0.58% $ 10.3m | |
Member of Scientific Advisory Board | no data | keine Daten | keine Daten | |
Member of Scientific Advisory Board | no data | keine Daten | keine Daten | |
Chairman of Scientific Advisory Board | no data | keine Daten | keine Daten | |
Independent Director | 3yrs | US$363.12k | 0% $ 0 | |
Member of Scientific Advisory Board | 13.6yrs | keine Daten | keine Daten | |
Independent Director | 1.1yrs | US$610.43k | keine Daten |
11.5yrs
Durchschnittliche Betriebszugehörigkeit
63yo
Durchschnittliches Alter
Erfahrener Vorstand: CPRX's board of directors are seasoned and experienced ( 11.5 years average tenure).